Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 15: Vascular Diseases Session

Date/Time: | Room:

Back to Previous



08:00:00 G. Mathur India Comparative rural/urban diabetic retinopathy prevalence study using low cost fundus camera
08:06:00 X. Li China Chinese guideline of DME: Background, evidence and limitation
08:12:00 G. Lang Germany Evaluation of ranibizumab and panretinal laser photocoagulation (PRP) in proliferative diabetic retinopathy (PDR) – 24months observational followup of the PRIDE study
08:18:00 C. Busch Germany Stay or switch? Continued antiVEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
08:24:00 L. Malheiro Portugal The influence of the vitreomacular interface on the response to antiVEGF treatment in branch retinal venous occlusions
08:30:00 J. Korobelnik France A realworld study to monitor patients with diabetic macular edema treated with intravitreal aflibercept: Interim analysis of APOLLON
08:36:00 D. Buryakov Russian Federation The combined laser treatment technology as an alternative to conventional laser treatment of diabetic macular edema
08:42:00 S. Crisostomo Portugal Retina of diabetic patients without observed retinal vascular changes: A longitudinal study
08:48:00 K. Tsuboi Japan Retinal vasculature and structural changes by projectionresolved optical coherence tomography angiography in branch retinal vein occlusion
08:54:00 N. Artha Dewi Indonesia The role of angiopoietin2 inhibitor on retinal pericyte loss reduction
09:00:00 S. Stewart United Kingdom Pragmatism of randomized clinical trials on ranibizumab for the treatment of diabetic macular edema: Impact on clinical outcomes
09:06:00 R. Dai China PlGF and VEGF changes after intravitreous injections of conbercept in PDR patients
09:12:00 A. Arrigo Italy Intravitreal ranibizumab for branch retinal vein occlusion complicated with macular edema in patients younger than 50 years
09:18:00 M. Jimenez Santos Spain Predictive factors of better outcomes by monotherapy with an intravitreal dexamethasone implant (ozurdex®) for branch retinal vein occlusion in clinical practice

Want to find out more about EURETINA activities?

Contact us
© EURETINA All rights reserved